• ABT-263 (Navitoclax): Precision Apoptosis Dissection in Leuk

  2026-04-27

  Explore how ABT-263 (Navitoclax) advances apoptosis research, with a focus on pediatric acute lymphoblastic leukemia models. This article uniquely integrates mechanistic detail, protocol optimization, and recent reference findings for informed assay design.

• 3-Bromopyruvate Induces Ferroptosis to Overcome Cetuximab Re

  2026-04-27

  This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab induces autophagy-dependent ferroptosis to overcome intrinsic and acquired cetuximab resistance in colorectal cancer cells. Mechanistically, restoration of FOXO3a activity potentiates ferroptosis, autophagy, and apoptosis, providing a new strategy for targeting resistant colorectal cancer.

• Calpain Inhibitor I, ALLN: Technical Guide for Apoptosis & I

  2026-04-26

  Calpain Inhibitor I, ALLN (SKU A2602) is a selective tool compound for blocking calpain I/II and cathepsin B/L activity in apoptosis assays, inflammation research, and ischemia-reperfusion injury models. This guide addresses practical handling, solubility, and workflow integration to support robust mechanistic studies. Use is limited to research settings and not intended for clinical or diagnostic applications.

• Azilsartan Medoxomil Monopotassium: Precision Workflows in H

  2026-04-25

  Azilsartan medoxomil monopotassium (TAK 491) stands apart as a potent, selective AT1 receptor antagonist, driving translational advances in essential hypertension, renal, and cardiovascular disease research. This article delivers detailed protocols, troubleshooting insights, and experimental strategies that maximize rigor and reproducibility for blood pressure regulation studies.

• MMV Pandemic Response Box: Novel Compounds vs. MDR Pathogens

  2026-04-24

  This study systematically screened 247 compounds from the MMV Pandemic Response Box to identify new antibacterial and antifungal agents active against multidrug-resistant (MDR) clinical isolates. The findings highlight several compounds with potent activity—some effective even against strains resistant to last-line therapies—underscoring their translational significance for future antimicrobial development.

• Precision in Cell Death Analysis: AO/PI Double Staining Kit

  2026-04-24

  Discover the science behind the AO/PI Double Staining Kit for advanced cell viability and apoptosis detection. This article explores mechanistic, protocol, and translational advances, offering new evidence-based perspectives for researchers.

• Azilsartan Medoxomil Monopotassium: Precision Tools for Hype

  2026-04-23

  Azilsartan medoxomil monopotassium (TAK 491) sets a new benchmark in essential hypertension treatment research, offering robust, selective AT1 receptor antagonism with sustained activity. This article delivers a stepwise experimental workflow, advanced troubleshooting insights, and practical translation of recent meta-analytic findings to maximize reproducibility and data quality in cardiovascular and renal studies.

• Network Meta-Analysis: Azilsartan Medoxomil Monopotassium in

  2026-04-23

  This systematic review and network meta-analysis rigorously evaluated the efficacy of azilsartan medoxomil (TAK 491) compared to other antihypertensive agents in mild-to-moderate hypertension. The findings show that azilsartan medoxomil 80 mg is likely the most effective agent for both systolic and diastolic blood pressure reduction, providing critical evidence for essential hypertension treatment research.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In

  2026-04-22

  Wang et al. (2018) systematically dissect the cellular entry mechanism of genotype III grass carp reovirus (GCRV104), demonstrating that clathrin-mediated endocytosis is essential for infection in fish kidney cells. Their pharmacological inhibitor analysis clarifies the roles of endocytic pathways and sets a methodological foundation for further studies in aquatic virology and drug screening.

• CP-673451: Selective PDGFRα/β Inhibitor for Advanced Cancer

  2026-04-22

  CP-673451 stands out as a highly selective PDGFRα/β inhibitor, enabling reproducible angiogenesis and tumor growth inhibition assays—even in complex ATRX-deficient glioma models. This guide delivers actionable workflows, troubleshooting strategies, and advanced insights to maximize research impact using CP-673451 from APExBIO.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Applicati

  2026-04-21

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody addresses the need for sensitive, specific detection of goat IgG in fluorescence-based assays, including ICC/IF, IHC, flow cytometry, and ELISA. It should be used strictly with goat primary antibodies in immunodetection workflows, as it is not validated for non-goat targets or non-fluorescent applications.

• ERK5 and ERK1/2 Pathways in Vitamin D-Induced AML Differenti

  2026-04-21

  This study elucidates the distinct roles of ERK5 and ERK1/2 MAPK pathways in the terminal differentiation of myeloid leukemia cells triggered by 1α,25-dihydroxyvitamin D3. Using selective pharmacological inhibitors, the authors demonstrate that ERK5 and ERK1/2 contribute differently to cell cycle arrest and differentiation, offering new mechanistic insights for combinatorial leukemia therapies.

• Novel 14-3-3 Interactors ATG9A and PTOV1 in Cancer Regulatio

  2026-04-20

  This study identifies ATG9A and PTOV1 as previously unrecognized 14-3-3 binding proteins involved in autophagy and oncogenic signaling. Mechanistic insights into their regulation reveal new layers of control over cancer-related pathways, informing future targets for conditional gene therapy and regulated cell therapy research.

• Tunable Human Intestinal Organoid System Balances Cell Fate

  2026-04-20

  This study introduces a human intestinal organoid culture platform that precisely modulates the balance between stem cell self-renewal and differentiation using small molecule pathway modulators. The system achieves higher proliferative capacity and cellular diversity without artificial gradients, enhancing organoid scalability for disease modeling and high-throughput research.

• Scenario-Driven Best Practices with Annexin V-PE Apoptosis K

  2026-04-19

  This article provides scenario-based, evidence-driven guidance for using the Annexin V-PE Apoptosis Detection Kit (SKU K2200) in advanced cell death assays. It addresses real laboratory obstacles faced by biomedical researchers and technicians, demonstrating how this kit offers reproducible, rapid, and sensitive live-cell apoptosis detection for robust data generation.

449 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page